| Trial ID: | L0423 |
| Source ID: | NCT01232257
|
| Associated Drug: |
N-Acetylcysteine
|
| Title: |
Effect of N-acetylcysteine (NAC) on Hydrogen Sulfide (H2S) in Chronic Kidney Disease (CKD)
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Kidney Disease|Chronic Kidney Failure|End Stage Kidney Disease|End Stage Renal Disease
|
| Interventions: |
DRUG: N-acetylcysteine
|
| Outcome Measures: |
Primary: Hydrogen sulfide (H2S), Investigate the effect of N-acetylcysteine on plasma H2S levels and on markers of oxidative stress, inflammation, and endothelial dysfunction in healthy volunteers, CKD patients, and dialysis patients, After 48 hours |
|
| Sponsor/Collaborators: |
Sponsor: A.C. Abrahams
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
28
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2011-07
|
| Completion Date: |
2011-12
|
| Results First Posted: |
|
| Last Update Posted: |
2012-10-26
|
| Locations: |
UMC Utrecht, Utrecht, 3584 CX, Netherlands
|
| URL: |
https://clinicaltrials.gov/show/NCT01232257
|
